Search PubMed⌕ Search

Biomedical subjects

M F Ivey

Publications and source records attributed to M F Ivey.

32 records · Page 2Linked to original sources
PubMed1983

Pharmacy department costs and patient charges associated with a home parenteral nutrition program.

The pharmacy department costs of a home parenteral nutrition (HPN) program were identified, and the patient charges for HPN were compared with the charges for hospitalization for parenteral nutrition. Ten patients were randomly selected from 55 patients active in the HPN program at the University of Washington Hospital. Cost identification included quantification of supplies, personnel, equipment, freight, miscellaneous, and indirect costs. Patient charges were identified through billing documents. Charges included clinic visits and laboratory tests. Inpatient charges were identified in a similar manner and included a standard daily hospital charge. Average yearly costs to the pharmacy department were nearly +9000 per HPN patient. Patient charges for HPN were +48.19 per infusion day compared with +205.68 per infusion day for the hospitalized patient. The cost savings of HPN to the patient and the hospital were clearly demonstrated.

Costs and Cost Analysis↗
PubMed1983

Subjective assessment of patient outcomes of home parenteral nutrition.

The medical, financial and psychosocial impact of home parenteral nutrition (HPN) therapy on patients' lives was assessed. A questionnaire that solicited patient characteristics and therapeutic outcomes of HPN therapy, such as number of hospital admissions, physiological complaints, and psychosocial interferences, was sent to 49 patients currently participating in a HPN program based at a university hospital. Questionnaires were returned by 42 patients. HPN-related complications were responsible for 39% of all reported hospital admissions during the previous year; of these, 27% were related to HPN catheters. Patients reported few physiological complaints, except for cramping in the hands and feet. Patients who complained of diarrhea had significantly more physiological complaints and psychosocial interferences than those who did not. The majority of patients had medical insurance coverage, but 26% had to pay at least part of the costs of HPN therapy. Only 25% of patients who were able to work did so. Most patients believed that HPN therapy had a very positive effect on their lives. The majority of patients in this HPN program appear to have a reasonable quality of life.

Adult↗
PubMed1979

A 'mini-residency' in drug information for the practicing pharmacist.

Continuing education "mini-residencies" in drug information services were sponsored by the University of Washington School of Pharmacy's Division of Continuing Education and the University of Washington Drug Information Service (DIS) in August of 1976, 1977, and 1978. Each mini-residency covered a two-week period (a total of 80 hours) and was divided into didactic and experimential sessions. The university's DIS was the major resource for the residents. The two-week residency was designed to provide education and experience in the areas of drug information retrieval, analysis, and dissemination. The program was assessed through pre- and post-testing and a midcourse evaluation session. The residency format of the program allowed practicing pharmacists to return to the university to develop their skills in the area of drug information. The article presents a model for other drug information pharmacists who may want to offer similar training programs.

Curriculum↗
PubMed1979

Savings achieved through use of a less concentrated amino acid solution.

The administrative process of adding a 5.5% crystalline amino acid solution to the formulary of two affiliated hospitals and the results of the addition are discussed. A formulary change was sought after it was found that many patients on parenteral nutrient therapy were receiving more amino acids than they needed. Nearly all patients on parenteral nutrient therapy were receiving 8.5% crystalline amino acid solution. The approach to achieving the pharmacy and therapeutics committee's approval of the formulary change included documenting amino acid needs from the literature, securing a multidisciplinary base of support and providing economic impact information. A standard TPN order form for physicians, education through the pharmacy newsletter, and presentations at surgery and medical conferences and grand rounds were implemented to assure that the change was effective. During the 12 months following approval of the formulary addition, 66% of the more than 20,000 total parenteral nutrient solutions were prepared using 5.5% amino acid solutions. This resulted in an annual savings of $41,028

Amino Acids↗
PubMed1978

Right atrial indwelling catheter for patients requiring long-term intravenous therapy.

The use of a central venous catheter for long-term intravenous therapy is described. The catheter's history, physical description, and uses are discussed. Also reviewed are complications from use of the catheter, the pharmacist's role in patient teaching, and the procedure for administering medications through the catheter. A listing of drugs administered through the catheter, incompatibility data and patient teaching instructions are also included.

Catheters, Indwelling↗
PubMed1977

Administrative case study: the patient care area pharmacist.

The development and implementation of a patient area pharmacist position is described. Difficulties which led to the creation of this position are discussed. Primary duties of the position include improving communications with personnel in the patient care areas, reducing the work load and pressure within the pharmacy, and providing nonproduct and clinical services to health care personnel. The advantages and disadvantages of the position are discussed.

Hospital Departments↗
PubMedDate not supplied

Supplementation of total parenteral nutrition solutions with ferrous citrate.

Daily infusion of a total parenteral nutrition (TPN) formulation containing 1 liter of 5.5% Travasol provides less than 0.1 milligrams of iron. By comparison, a formulation which includes a liter of 10% Travamin provides 2 milligrams of iron per day. To meet iron requirements in patients infusing formulations containing Travasol, iron was added as ferrous citrate. In in virto experiments, 74% of this iron was available to transferrin. In seven patients in whom in vivo availability was tested by red cell incorporation, the mean availability was 81%. Ferrous citrate is recommended as a safe, effective additive to TPN solutions for adult patients requiring iron supplements.

Adult↗